🇺🇸

Distress Insolvency

· daily

US Corporate Distress Financial Stress SEC Filings — June 17, 2026

The 45 filings reveal a bifurcated corporate distress landscape: several companies face acute bankruptcy/delisting risks (Sleep Number, Vestand, Workhorse, Gencor) while others execute strategic refinancings or M&A to strengthen balance sheets (Dyne Therapeutics, Kilroy Realty, HEICO). Notable period-over-period trends include margin compression in office REITs (Kilroy occupancy 77.6%) and revenue growth in licensing (Playboy Q1 2026 Adjusted EBITDA doubled YoY). Insider activity is sparse but includes a significant share repurchase from a departing chairman (South Plains Financial). Capital allocation patterns show a shift toward debt reduction (Playboy $52M earmarked) and equity-linked financing (iQSTEL 24% preferred, AIxCrypto 93% VWAP). The most critical developments are Sleep Number's Chapter 11 delisting and Bed Bath & Beyond's transformative acquisition of Fathom Holdings, signaling potential value creation or further distress. Portfolio-level patterns include a wave of credit facility amendments (10+ filings) and reverse stock splits (Allurion) as companies manage liquidity.

45 high priority 45 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 16, 2026

This batch of 36 filings paints a stark picture of corporate distress, with a surge in bankruptcy filings and liquidity-driven restructuring. Sleep Number Corp's Chapter 11 filing and FiscalNote's debt waiver request are the most acute distress signals, while companies like CEL-SCI and LIXTE Biotechnology (via a reverse merger) highlight the desperation for capital and strategic pivots. There is a clear bifurcation in the credit markets: highly distressed firms are diluting equity and restructuring debt, while healthier companies (Rocket, Dell, Matador) are proactively refinancing at longer maturities, albeit often at higher rates. The most actionable intelligence centers on a wave of M&A as both a distress exit (Open Lending) and a capital allocation strategy (Yum! Brands/China, Olin/Huntsman), but investors must beware the significant execution and integration risks flagged in several deals. Notably, period-over-period comparisons are sparse in these event-driven filings, but the presence of debt-for-equity swaps, distressed asset sales (Bright Mountain Media), and dependence on novel financing (Applied Digital's AI data center build-out) are all high-risk patterns demanding close monitoring.

36 high priority 36 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 15, 2026

The 50 filings from June 15, 2026, paint a picture of a market bifurcated between aggressive corporate restructuring and strategic M&A. A dominant theme is the use of high-yield debt and convertible notes to refinance or raise capital, with several companies (Owens & Minor, Jack in the Box, Cipher Mining) issuing new notes at significantly higher interest rates (7.6% to 9.75%) to replace lower-coupon debt, signaling increased leverage costs. Concurrently, there is a wave of major M&A and divestiture activity, including Fox's $22B acquisition of Roku, Nuvei's $2.75B purchase of Payoneer, and Comtech's $157.5M segment sale, indicating sector consolidation. Distress signals are also prominent, with three companies (Functional Brands, ESS Tech, Momentus) facing delisting or NYSE non-compliance, and several others (Healthcare Triangle, Zeo Energy) engaging in highly dilutive, high-cost financing. Insider activity is sparse but notable, with a debt-to-equity conversion by insiders at RenX Enterprises. The overall sentiment is mixed, with a clear divergence between well-capitalized firms executing strategic moves and distressed entities fighting for survival.

50 high priority 50 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 12, 2026

This digest of 50 US SEC filings from June 12, 2026, reveals a pronounced wave of corporate distress, particularly among small-cap and micro-cap companies. The most critical theme is a cluster of bankruptcy, delisting, and going-concern warnings, with Sleep Number Corp's Chapter 11 filing being the most severe event, signaling a complete loss for common equity holders. A secondary theme is the aggressive use of high-cost, dilutive financing (convertible notes, ATM offerings, and secured loans with interest rates up to 16%) by cash-strapped companies like BioRestorative Therapies, Genasys, and Edible Garden AG, indicating severe liquidity constraints. Conversely, a few larger entities like Super Micro Computer and Delta Air Lines are accessing capital markets on favorable terms for growth and refinancing, highlighting a bifurcated market where access to capital is a key differentiator. The data shows a high frequency of Nasdaq deficiency notices (Soligenix, La Rosa, Genprex, etc.), suggesting a systemic issue with micro-cap listed companies failing to meet minimum listing standards. Insider activity is limited but telling, with director resignations at BioRestorative Therapies coinciding with a lender-forced board change, a classic distress signal. Forward-looking statements are predominantly negative, with multiple companies disclosing uncertain futures, ongoing negotiations with lenders, and strategic alternatives evaluations.

50 high priority 50 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — June 12, 2026

The sole filing in this session is a high-materiality Chapter 11 filing from Sleep Number Corp (SNBR), which has entered a 363 sale process with Sleep Country Canada as the stalking horse bidder. The company secured up to $260M in DIP financing (including $65M new money) to maintain operations across 570+ stores during the proceedings. However, the purchase price is expected to render common equity worthless, and the company has already moved to reject leases on 44 non-operational locations. This filing signals a definitive end for equity holders and a structured exit via asset sale, with no period-over-period comparisons or insider activity data available to assess prior trends. The key theme is a distressed retail bankruptcy with a pre-arranged stalking horse, limiting upside for unsecured creditors and equity but providing operational continuity for the business.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 11, 2026

The 41 filings from June 11, 2026, paint a picture of a market with significant capital churn and distress signals, particularly in the small-cap and pre-revenue biotech sectors. A dominant theme is the aggressive use of equity-linked financing (convertible notes, PIPEs, equity lines) by cash-burning companies like PureCycle, AIM ImmunoTech, and Atossa Therapeutics, signaling ongoing liquidity pressure. Conversely, several energy and industrial firms (Presidio Production, Venture Global, AECOM) are successfully refinancing debt at lower costs, indicating a bifurcation between distressed and healthy balance sheets. The most critical development is the Chapter 11 filing and Nasdaq delisting of GoHealth, a high-materiality event that underscores the risks in the insurtech space. Portfolio-level trends show a clear pattern of distressed companies using reverse stock splits (Verano, Shuttle Pharma) to maintain listing compliance, while larger firms (Ciena, IQVIA) execute large-scale debt offerings for refinancing and strategic purposes. Insider activity is limited in these filings, but the CEO-led PIPE at Edesa Biotech provides a positive signal, contrasting with the general lack of insider buying in most distressed issuers.

41 high priority 41 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 10, 2026

This intelligence stream reveals a bifurcated corporate landscape: while capital-intensive sectors like data centers and AI infrastructure are attracting massive debt financing (e.g., Hut 8's $4.25B notes, Amazon's $17.5B loan), a parallel wave of distress is sweeping through smaller, cash-burning entities. The most critical theme is a surge in dilutive financing and costly debt restructurings, with 8 companies engaging in equity or convertible offerings and 3 companies executing high-interest refinancings (B&G Foods at 11.00%, Pacific Oak at 11.5%). Period-over-period data, though limited in this batch, shows margin compression at TPG Twin Brook (ROE down 80 bps YoY) and a clear pattern of companies trading financial health for survival. Insider activity is notably absent, but management actions—like Aditxt spinning off a subsidiary at a $150M valuation while the parent struggles—signal a 'hive-off' strategy to unlock value. The forward-looking data is dominated by catalyst dates (hearings, offering closings) that will determine the fate of several distressed names, making the next two weeks critical for portfolio positioning.

37 high priority 37 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 09, 2026

The 32 filings reveal a bifurcated landscape: robust M&A activity (Nuvalent, Novanta, Ingredion, Cycurion) and capital markets access (Arch Capital, Cheniere, PennantPark) contrast sharply with distress signals from micro-cap companies facing Nasdaq non-compliance, dilutive financings, and cash burn. Period-over-period data shows mixed trends—Soluna's 58% YoY revenue growth and record hash rate contrast with NexPoint's declining Core FFO and margin compression. Insider activity is limited, but debt-to-equity conversions (Rain Enhancement) and PIPE deals (HWH International) indicate financial strain. Key themes include healthcare/biotech M&A at premium valuations, energy infrastructure debt issuance, and a wave of reverse stock splits and going concern warnings among small caps. The most critical developments are the $10.6B Nuvalent acquisition, Ingredion's $5.0B Tate & Lyle bid, and multiple Nasdaq deficiency notices (Professional Diversity Network, Jasper Therapeutics).

32 high priority 32 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 08, 2026

This intelligence stream reveals a bifurcated corporate landscape: a wave of distressed companies is resorting to dilutive financing, reverse mergers, and Chapter 11 filings to survive, while a separate cohort of fundamentally sound firms is aggressively accessing capital markets for growth and acquisitions. The most critical developments include three bankruptcy filings (GoHealth, Silver Star Properties, and a prepackaged restructuring) and multiple going-concern warnings signaled by dilutive offerings and debt restructurings. Key period-over-period trends from the data show a stark contrast: Village Farms' revenue grew 15% YoY while Cerus increased its debt load by $5M, and FICO's $2B buyback signals confidence versus Volato's speculative pivot. A portfolio-level pattern emerges in the energy and solar sectors, where SUNation's reverse merger and Vivakor's $108M annualized crude oil deal highlight a push for scale and revenue diversification. The most actionable intelligence lies in tracking the 5 companies with imminent bankruptcy risks and the 3 companies with significant capital allocation events that could drive shareholder value.

48 high priority 48 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — June 08, 2026

The two bankruptcy filings on June 8, 2026, reveal a bifurcated distress landscape: one prepackaged, consensual restructuring (GoHealth) versus an emergency, contested filing (Silver Star Properties REIT). GoHealth’s filing is a structured balance sheet cleanup with 100% lender support, aiming for a quick emergence before the 2026 enrollment period, but it destroys common equity value and triggers a Nasdaq delisting. Silver Star’s filing is a reactive, high-urgency Chapter 11 driven by four loan defaults totaling $65.2 million and an imminent foreclosure on a $5.75 million promissory note, signaling severe liquidity crisis. Period-over-period comparisons are not explicitly available in the raw filings, but the contrast in preparation—GoHealth’s prepackaged consensus vs. Silver Star’s last-minute filing—highlights a key trend: companies with lender alignment can preserve operational continuity, while those without face asset fire sales. The materiality is extreme (9/10 and 10/10), with immediate implications for equity holders, creditors, and sector sentiment in healthcare services and specialty REITs.

2 high priority 2 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 05, 2026

This batch of 48 SEC filings reveals a pronounced bifurcation in corporate health, with a cluster of companies in acute distress—evidenced by forbearance agreements, Nasdaq deficiency notices, and distressed debt exchanges—while others execute strategic refinancings and capital raises. The most critical themes are a wave of liquidity crises among small-cap industrials and tech firms, aggressive debt refinancing at higher costs signaling credit stress, and a surge in at-the-market (ATM) equity offerings that dilute existing shareholders. Period-over-period data, where available, shows revenue declines and cash burn rates that are unsustainable, with several companies having less than six months of runway. Conversely, a few companies like Brown & Brown and Synchrony Financial are successfully accessing capital markets on favorable terms, indicating a healthy credit environment for investment-grade entities. The overall picture is one of increasing divergence, where well-capitalized firms are strengthening their balance sheets while weaker players face existential threats, creating both high-risk and high-opportunity scenarios for investors.

48 high priority 48 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 04, 2026

This intelligence stream reveals a significant bifurcation in corporate health across 48 filings. A dominant theme is acute liquidity distress among micro-cap and pre-revenue companies, with 10+ filings involving emergency insider loans, distressed debt exchanges, or going-concern warnings. Concurrently, a wave of capital markets activity—including $1.2B+ in new debt and equity offerings—signals both opportunistic refinancing and desperate cash grabs. Notable period-over-period trends include a sharp increase in refinancing costs (e.g., B&G Foods' coupon jumping from 5.25% to 11.00%) and a surge in spin-off/divestiture activity aimed at unlocking value. Insider activity is sparse but telling, with related-party loans and CFO departures flagging governance risks. The most critical developments include multiple Nasdaq non-compliance notices, a $2.0B non-binding financing term sheet with a $25M non-refundable fee, and a $50M antitrust settlement. The overall market implication is a 'flight to quality' where companies with strong balance sheets are capitalizing on dislocation, while weaker players face a binary outcome.

48 high priority 48 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 03, 2026

This batch of 46 filings reveals a pronounced bifurcation in US public markets: a wave of deeply distressed micro-caps engaging in emergency financing, reverse splits, and delinquent filings contrasts sharply with a handful of fundamentally sound companies opportunistically refinancing and securing transformational government backing. The dominant theme is acute liquidity stress, with at least 15 companies executing dilutive capital raises (debt/equity), 5 companies receiving NYSE/Nasdaq deficiency or delisting notices, and 3 firms filing for or teeing up Chapter 11 restructuring. Period-over-period data, where available, confirms deteriorating trends: Katapult's multiple loan waivers, Kingfish's shift to 90-day loan extensions, and Reed's sub-$4M equity underscore systemic working capital crises. On the positive side, USA Rare Earth's $1.6B CHIPS Act funding, Mineralys' $200M buyout of royalty obligations, and TTM Technologies' 50bps Term Loan B repricing highlight strategic wins. Insider activity is predominantly neutral/absent in these filings, but several director-led placements (IR-Med, Range Impact) signal insider alignment albeit at distressed levels. The most actionable signal is the impending Inotiv prepackaged Chapter 11 filing—the highest materiality event in this batch—while the deteriorating covenant compliance patterns at Katapult and Kingfish demand immediate monitoring.

46 high priority 46 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — June 03, 2026

This session was extremely quiet with only one pre-analyzed filing: Inotiv, Inc.'s 8-K detailing a prepackaged Chapter 11 plan of reorganization. The filing signals a structured, consensual restructuring attempt, supported by a substantial majority of claim holders, which reduces the risk of a contentious bankruptcy. However, the company has not yet filed the Chapter 11 petition, and the disclosure statement remains unapproved by the court, creating procedural uncertainty. The pre-petition solicitation is limited to accredited investors and QIBs, indicating a targeted approach to secure plan confirmation. The negative sentiment and high materiality (10/10) underscore a critical juncture for Inotiv's capital structure and equity value. With no other filings in the stream, the focus is entirely on the execution and timeline of this restructuring, with the vote deadline of July 6, 2026, as the next key catalyst.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 02, 2026

The 48 filings in this intelligence stream reveal a bifurcated corporate landscape dominated by aggressive capital restructuring, elevated refinancing activity, and a clear 'survival of the fittest' dynamic. A significant cohort of companies, particularly in energy and industrials (Hallador, Granite Construction, Peabody), are executing transformative, multi-billion dollar projects or recapitulations, often accompanied by high-yield debt offerings at rates of 6.375% to 7.75%, signaling both conviction and a high cost of capital. Simultaneously, a cluster of micro-cap and stressed entities (Tempest Therapeutics, C2 Blockchain, NKGen Biotech) are resorting to deeply dilutive financings and convertible notes with 10% OIDs to secure small cash infusions, effectively worsening their equity positions for near-term liquidity. The data shows a strong trend of liability management and covenant amendments—from Atlantic American Corp needing a waiver for financial statement delivery to Curbline Properties launching a $400M ATM to scout for acquisitions. A nascent thematic is the emergence of insider-driven 'recapitalizations,' like Greenpro Capital's CEO and LQR House's controlling stake purchase in profitable assets, suggesting that management sees intrinsic value despite market skepticism. The most actionable insight is the prevalence of M&A as both a distress signal and an opportunity, with the NCS Multistage/Weatherford and Arxis/Ominetics deals providing clear floor prices, while the Hertz ABS issue at rates up to 9.64% flags acute credit risk in the rental car sector. Overall, the market is pricing in high uncertainty, favoring deep-dive credit analysis and event-driven plays over broad sector exposure. Key forward-looking catalysts are heavily loaded in late 2026 and 2028, making the next 6-12 months a critical period for execution on these announced plans.

48 high priority 48 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 01, 2026

This intelligence digest synthesizes 50 pre-analyzed SEC filings from June 1, 2026, revealing a pronounced bifurcation in corporate health. While 12 companies are executing aggressive capital structure improvements (e.g., FedEx Freight spin-off, Bright Horizons refinancing, Dropbox buyback), the distress stream is dominated by 8 high-risk bankruptcy/going-concern signals, including a Chapter 11 filing (Trinseo), multiple missed interest payments (Inotiv), and Nasdaq delisting threats (iSpecimen, Nuburu, HCW Biologics). A clear sector theme emerges: capital-intensive industries (energy, manufacturing, REITs) are actively de-levering, while cash-burning biotechs and small-cap tech firms face acute liquidity crises. Insider activity is sparse but notable, with Chairman Einhorn's share repurchase agreement at Greenlight Capital Re signaling tax-driven ownership management. Forward-looking data points to a catalyst-rich Q3 2026, with major M&A closings (Taylor Morrison, Edgewise/Servier) and critical regulatory deadlines (Nuburu's Italian Golden Power approval). The most actionable insights lie in the distressed debt space, where companies like System1 and Optimum Communications are executing complex restructurings that could unlock significant value for patient capital.

50 high priority 50 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 29, 2026

The 49 filings reveal a surge in corporate distress signals, with 10 companies receiving Nasdaq non-compliance or delisting notices, primarily due to late filings or equity deficiencies. Notable distress includes Aditxt (negative equity of -$35M), Edible Garden (imminent suspension), and Gulf Resources (multiple delinquencies). Capital markets activity is mixed: several companies raised debt (Xylem $1B, Kennedy-Wilson $1.8B, Navient $500M) or equity (Momentus $25M, Wellgistics $21.1M), while others like GrafTech and Solana expanded ATM programs. M&A activity continues with Cycurion acquiring Secuvant for $3M, CoStar buying Zonda for $800M, and Healthy Choice Wellness acquiring Host Digital. Insider trading data is sparse, but the high number of going concern warnings and equity issuances suggests management caution. Period-over-period comparisons are limited as most filings are event-driven, but Avalanche Treasury's net loss of $139,635 and zero cash highlight severe cash burn. The overall theme is a bifurcated market: well-capitalized firms access debt markets cheaply, while distressed micro-caps scramble for survival.

49 high priority 49 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 28, 2026

The 49 filings from May 28, 2026, reveal a market bifurcated between aggressive corporate actions (M&A, refinancing) and acute financial distress, particularly among small-cap and micro-cap companies. A dominant theme is the wave of refinancing and debt restructuring, with companies like Kinder Morgan, Hexcel, PBF Energy, and Kennametal extending maturities and managing balance sheets, while distressed entities like Nature's Miracle, Celularity, and Allbirds engage in survival-mode settlements and covenant amendments. Distress signals are concentrated in Nasdaq compliance failures, with Lulu's Fashion Lounge, CDT Equity, and Richtech Robotics receiving deficiency notices, and distressed financing (PIPEs, high-interest loans) from ENDRA Life Sciences, Vestand, and Polaryx Therapeutics. On the opportunity side, high-value M&A is a key catalyst, including the $17.6B acquisition of Caesars Entertainment, Autodesk's $3.6B acquisition of MaintainX, and Apogee Enterprises' accretive acquisition of Kalwall. Sector themes point to a capital rotation from distressed small-caps to larger, cash-rich acquirers, with energy infrastructure (Cheniere, Sabine Pass) and AI infrastructure (Boost Run) seeing significant long-term investment commitments. The overall sentiment is cautiously optimistic for large caps with strong balance sheets, but highly bearish for micro-caps facing liquidity crises and potential delisting.

49 high priority 49 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 27, 2026

The 50 filings from May 27, 2026, paint a stark picture of a bifurcated market: a wave of distressed micro-caps is aggressively seeking emergency capital through dilutive ATMs, convertible notes, and private placements, while larger, more stable companies are opportunistically refinancing debt and pursuing strategic M&A. The most critical theme is the surge in Nasdaq non-compliance and going-concern risks, with at least five companies (Borealis Foods, Greenwave Technology, Liminatus Pharma, SOBR Safe, Callan JMB) facing potential delisting. This distress is concentrated in the small-cap biotech and technology sectors, where cash burn and failed trials are forcing existential restructuring. In contrast, the energy and digital infrastructure space is seeing significant capital deployment, highlighted by DigitalBridge's $1.05B acquisition of ArcLight and newcleo's $2.4B SPAC merger. Insider activity is notably absent from these filings, but capital allocation patterns—aggressive dilution vs. strategic debt refinancing—clearly separate the survivors from the distressed. The period-over-period data from BDCs (Golub Capital, PennantPark) shows flat-to-declining net asset values, signaling a cautious outlook for credit markets. The most actionable intelligence lies in the distressed names where the structure of rescue financing (e.g., HWH International's control-diluting deal) creates both extreme risk and potential for asymmetric returns.

50 high priority 50 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 26, 2026

The 42 filings from May 26, 2026, paint a stark picture of a bifurcated US corporate landscape. While a handful of companies (Ares Capital, IREN, Allied Gaming) are executing large-scale, growth-oriented capital raises and acquisitions, a significant cohort is exhibiting classic distress signals. The most critical development is Trinseo PLC's Chapter 11 filing, which confirms a major restructuring in the chemicals sector and serves as a high-severity warning for other over-levered industrials. A secondary wave of distress is evident in the micro-cap and biotech space, with at least five companies (Nuvve, Vestand, TEN Holdings, World Acceptance, Future FinTech) receiving Nasdaq deficiency notices or requiring covenant relief, indicating systemic liquidity pressure. The dominant theme is a 'flight to quality' in capital markets, where well-capitalized firms easily access billions in credit (Ares, Encore Capital), while distressed entities are forced into dilutive equity offerings (Editas, Assembly Biosciences) or high-cost debt (LiqTech, Future FinTech). Insider activity, where observable, is mixed, but the pattern of repeated debt extensions (Odyssey Health) and governance changes to centralize control (Motorsport Games) are clear red flags for equity holders. The forward-looking data reveals a catalyst-rich calendar, with several Phase 3 clinical trial readouts (Cartesian, Editas) and transformative M&A closings (Allied Gaming, Northern Oil & Gas) that will define the next quarter's winners and losers.

42 high priority 42 total filings